Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Effect of Single Dose Dexmedetomidine Versus Midazolam on Emergence Agitation and Recovery Profile When Added to Ketamine for Procedural Sedation and Analgesia in Pediatric Patients Undergoing Bone Marrow Aspiration and Biopsy


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03647579

Organisation Name: Assiut University

Overal Status: Completed

Start Date: August 30, 2018

Last Update: October 3, 2019

Lead Sponsor: Assiut University

Brief Summary: Group I :The patients will receive midazolam intravenously (i.v.) in a dose of 0.05 mg/kg diluted by 50ml saline over 10 minutes using syringe pump plus 1 mg/kg ketamine (iv).

Group II : The patients will receive Dexmedetomidine intravenously (i.v.) in a dose of 2mic/kg diluted by 50ml saline over 10 minutes using syringe pump plus 1 mg/kg ketamine (iv).

The objective of this study to evaluate the clinical effects, adverse effects and recovery time of two different sedative agents (midazolam and Dexmedetomidine) combined with ketamine during conscious sedation for child patient with haematological cancer undergoing BMA &biopsy.

Conditions:
  • Procedural Sedation and Analgesia During Bone Marrow Aspiration and Biopsy


Total execution time in seconds: 0.15351104736328